SCHEMBL819920

SCHEMBL819920

CC(C)(C)c1ccc(OBO)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.48
RAB9A P51151 3/20 0.48
ALDH1A1 P00352 2/20 0.48
MAPK1 P28482 2/20 0.48
NPC1 O15118 2/20 0.48
HPGD P15428 1/20 0.48
LMNA P02545 2/20 0.48
TYR P14679 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
TDP1 Q9NUW8 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TSHR P16473 1/20 0.44
ALOX15 P16050 1/20 0.43
APEX1 P27695 1/20 0.43
RECQL P46063 1/20 0.43
HSD17B10 Q99714 1/20 0.43
NPY1R P25929 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14477632 0.82 MEN1 (0.33) CA1CA2CA9MEN1KMT2A
SCHEMBL452367 0.80 MAPT (0.52) MAPTRAB9AALDH1A1MAPK1NPC1
SCHEMBL17191780 0.79 GABRA1 (0.46) MAPTALDH1A1HPGDLMNATYR
SCHEMBL820257 0.79 KIF11 (0.44) ALDH1A1CA1CA2CA9TSHR
SCHEMBL1542267 0.79 MAPT (0.61) MAPTRAB9AALDH1A1MAPK1NPC1
SCHEMBL17343658 0.77 CYP3A4 (0.44) MAPTRAB9AALDH1A1MAPK1NPC1
SCHEMBL12045431 0.76 CA2 (0.44) CA1CA2TSHR
SCHEMBL819814 0.75 CA1 (0.58) MAPTRAB9AALDH1A1MAPK1NPC1
SCHEMBL10236245 0.75 MAPT (0.58) MAPTRAB9AALDH1A1MAPK1NPC1
SCHEMBL2602434 0.75 ACHE (0.48) MAPTALDH1A1LMNACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-11858952-B2 Compound and color conversion film comprising same LG CHEM, LTD. (KR) 2024-01-02 US disclosed
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD (JP) 2023-05-04 US disclosed
US-11641776-B2 Organic compound, organic light emitting diode and organic light emitting device having the compound LG DISPLAY CO., LTD. (KR) 2023-05-02 US disclosed
US-20230126543-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-04-27 US disclosed
US-20200365812-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-11-19 US disclosed
US-9920167-B2 Polymer and organic light-emitting diode including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-03-20 US disclosed
US-9905773-B2 Compound for organic electronic element, organic electronic element using the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2018-02-27 US disclosed
US-20140058106-A1 SYSTEM FOR FLUORINATING ORGANIC COMPOUNDS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2014-02-27 US disclosed
US-20130146849-A1 POLYMER AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-06-13 US disclosed
US-20130037790-A1 NOVEL 10,10-DIALKYLANTHRONE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-02-14 US disclosed
US-8361959-B2 Spiro-imidazolone derivatives as glucagon receptor antagonists MERCK SHARP & DOHME CORP. (US) 2013-01-29 US disclosed
US-20130012434-A1 NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE MERCK SHARP & DOHME CORP. 2013-01-10 US disclosed
US-8183793-B2 Method for synthesizing anthracene derivative and anthracene derivative, light emitting element, light emitting device, electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-22 US disclosed
US-20110054175-A1 SYSTEM FOR FLUORINATING ORGANIC COMPOUNDS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2011-03-03 US disclosed
US-20110050118-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-03-03 US disclosed
US-7789943-B2 Metal, ligand molecular sieves; temperature adjustable pores; controlling particle size MIAMI UNIVERSITY (US) 2010-09-07 US disclosed
US-20080184881-A1 MESH-ADJUSTABLE MOLECULAR SIEVE MIAMI UNIVERSITY (US) 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140058106-A1 SYSTEM FOR FLUORINATING ORGANIC COMPOUNDS PFAS, ODC1, AOC1 MAPT 2637/4885RAB9A 175/4885ALDH1A1 969/4885
US-20110050118-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE ALAD, CYP2C9, CYP1A1 MAPT 4161/4885RAB9A 1605/4885ALDH1A1 34/4885
US-20080184881-A1 MESH-ADJUSTABLE MOLECULAR SIEVE TRPA1, TRPM4, TRPV4 MAPT 1936/4885RAB9A 2712/4885ALDH1A1 3677/4885
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 MAPT 679/4885RAB9A 3347/4885ALDH1A1 1010/4885
US-11641776-B2 Organic compound, organic light emitting diode and organic light emitting device having the compound CYBA, CYP2C9, CYP3A4 MAPT 599/4885RAB9A 2318/4885ALDH1A1 1187/4885
US-20230126543-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CYP1A1, AOX1, CRY1 MAPT 2443/4885RAB9A 2986/4885ALDH1A1 12/4885
US-20130012434-A1 NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE GLP1R, GCGR, GIPR MAPT 4833/4885RAB9A 2550/4885ALDH1A1 1773/4885
US-11858952-B2 Compound and color conversion film comprising same BLVRB, CDYL, CRY1 MAPT 360/4885RAB9A 959/4885ALDH1A1 689/4885
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND DDT, DDC, ODC1 MAPT 1595/4885RAB9A 2282/4885ALDH1A1 152/4885
US-20110054175-A1 SYSTEM FOR FLUORINATING ORGANIC COMPOUNDS PFAS, ODC1, AOC1 MAPT 2637/4885RAB9A 175/4885ALDH1A1 969/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 MAPT 679/4885RAB9A 3347/4885ALDH1A1 1010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.